Lunula® Laser: The Most Effective, Efficient, and Clinically Proven Device for Treating Nail Fungus

100% Automated

Save on staff costs and increase profits. The perfect no-contact treatment.

Quick & Convenient

Non-invasive 12 minute treatments with outstanding results.

Fast ROI

Make your investment back in months. We’ll help you at every stage.

Erchonia’s non-thermal lasers are the only Low-Level Laser Therapy (LLLT) devices to be FDA Market Cleared for treating fungal nail infections (onychomycosis) – FDA Level One (510k) clearance is the ‘gold standard’, requiring placebo controlled, double blind, randomised, and multi-centre studies. The treatments are short, effective, and automated, allowing you to save on staff costs and increase profits. There is no associated pain, reported side effects, or downtime, and the technology is safe with no health risks. We provide the training, ongoing support, and marketing, so you can focus on what matters most – your clients.


About Lunula® Laser
About Lunula® Laser
Proven to Give the Best Results

About Lunula® Laser

Erchonia’s Lunula® Laser is the only LLLT device to be FDA Market Cleared for treating nail fungus.

Lunula® is easy to set up and use, and is the only automated system on the market today, allowing you to save on staff costs and increase profits.

> Download Data Sheet

Most Advanced Laser Therapy Technology

How Lunula® Laser Works

The Lunula® Laser targets onychomycosis through the use of two true laser beams (red 635nm and violet 405nm – monochromatic, collimated, and coherent). The two wavelengths trigger a photochemical reaction, producing Reactive Oxygen Species which is converted to Hydrogen Peroxide – a natural antiseptic that kills onychomycosis. In addition, the red 635nm wavelength induces the production of Adenosine Triphosphate (ATP) which is converted to Nitric Oxide – aiding the natural immune response in fighting the infection.

How Lunula® Laser Works
How Lunula® Laser Works
Why Choose Erchonia®?

World Leaders in Laser Therapy Technology

With over 25 years of experience, 16,000+ devices in the market, and 18 FDA-clearances, Erchonia® Corporation are world leaders in Laser Therapy technology. Our range of non-thermal Low-Level Laser Therapy (LLLT) devices are used in many areas, including pain relief, fat removal, cellulite reduction, fungal nail treatment, and more. Based in the UK, Erchonia Lasers Ltd are a subsidiary organisation. We provide personal support to companies in Europe, Middle East, and Africa… Read More

About Erchonia® Corporation
About Erchonia® Corporation

91% Customer Satisfaction Rating

Our clients say it all: best products, service, training, and support.

Over 25 Years of Experience

Founded in 1996 – first Low-Level Laser in the world to gain FDA market clearance.

18 FDA (Level One 510k) Clearances

Proven by placebo controlled, double blind, randomised, and multi-centre studies.

16,000+ Devices in the Market

Leaders in the field with over $5 million invested in R&D at any one time.

Ogi Bagatin (CEO, Bagatin Clinics)
Ken de Groot (DC, DABCO, DABDA)
Martin Andersen (DC, CCEP, MCC)